Janssen Research & Development
Janssen Research & Development
See all stories related to Janssen Research & Development
Innovation
Could changes in your microbiome increase your risk of colorectal cancer?
That’s exactly what researchers at Johnson & Johnson are trying to find out. By partnering on a new study that’s looking at the role gut microbes may play in the disease—and focusing on the underrepresented groups most affected—they hope to advance early-detection strategies and potential treatments.
Personal stories
4 things COVID-19 taught an ER doctor about the power of resilience and hope
At the height of the outbreak in New York City, Dr. Ed Kuffner took a leave of absence from his job to volunteer at a Brooklyn hospital hard hit by the pandemic. He shares what the experience taught him about his own strengths—and ideas for coping during this unprecedented time.
Innovation
“I’m racing to screen thousands of molecules": These scientists are canvassing a vast library in search of a potential COVID-19 treatment
Johnson & Johnson has an expansive archive of existing drug compounds—and two researchers are leading the charge in combing through this molecular storehouse in pursuit of a possible breakthrough.
Innovation
Alzheimer’s disease: Why one company refuses to give up the search for a cure
It’s the sixth leading cause of death in the United States, with no existing cure. But these researchers are committed to finding better ways to diagnose, treat and prevent the debilitating disease, using everything from innovative biomarker tracking to a potential vaccine for early stage patients.
Innovation
Cracking the genetic code: Why gene sequencing may hold the key to intercepting diseases before they start
Cancer. Alzheimer’s. Even suicide risk. The clues to preventing these and other conditions could be found in our DNA—and these scientists are at the forefront of promising new genetic data research to uncover them.
Innovation
Have IBD? Read about the next frontier in disease research that taps into the microbiome
There are trillions of microorganisms living in your gut—and they might just be the key to helping treat diseases like Crohn’s and ulcerative colitis. Meet a researcher who spends her days exploring this microscopic world.
Innovation
Clinical trials 2.0: 5 ways Johnson & Johnson is helping revamp—and revolutionize—how they’re conducted
From working to broaden the pool of patients trials have traditionally studied to finding ways for people to participate from the comforts of home, we look at how the company is reinventing clinical trials in truly forward-thinking ways.
Innovation
4 questions for a scientist determined to find a functional cure for hepatitis B
Despite being one of the oldest viruses known to infect man, there’s been slow progress toward a cure for the disease. But a promising clinical trial, led by Janssen researcher Heather Davis, Ph.D., is sparking hope.
Latest news
New study shows researchers may be one step closer to intercepting lung cancer earlier
A team of scientists, including those from Janssen and the Lung Cancer Initiative at Johnson & Johnson, found that biomarkers related to the immune system may be able to aid doctors in identifying high-risk lung cancer patients—and treating them—at the earliest stage of the disease.
Latest news
5 things to know about the 2018 Janssen U.S. Transparency Report
The company just released its third annual report and leaders from across Janssen share some top takeaways, including a new initiative to include the list price and potential out-of-pocket costs for its most frequently prescribed medicine.